Researchers have explored the evolution of the genetic change that causes chronic myeloid leukaemia and show its ability to drive the disease.

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

Revenue in 2024 increased 342%year-over-year to US$134.3 million (RMB980.7 million), attributable in part to Takeda’s option payment and strong ...

ITV News star Rageh Omaar returns to screens after live health scare - The concerning broadcast led to Ofcom complaints from ...

David Warner fielded a rather provocative question during his first press conference as Karachi Kings captain in the PSL.

In extreme environments such as petrochemical plants, refining facilities, and high-temperature production lines, the ...

And the discovery could soon lead to personalized treatments for ... Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML ...

A landmark clinical trial in 2005 showed that 90% of patients taking Glivec for CML were alive after more than four years of treatment. According to Novartis, the Glivec International Patient ...

RSC International Ltd (formerly known as Ratangiri Textiles Limited ... 2024/185/dated December 31 2024 read with BSE Circular No. 20250102-4 and NSE Circular No NSE/CML/2025/02 dated January 02 2025 ...

Healthcare logistics giant Walden group has strengthened its European presence through a move into Italy involving the ...